Standout Papers

Rottlerin, a Novel Protein Kinase Inhibitor 1994 2026 2004 2015 776
  1. Rottlerin, a Novel Protein Kinase Inhibitor (1994)
    Michael Gschwendt, H.-J. Müller et al. Biochemical and Biophysical Research Communications
  2. Inhibition of protein kinase C μ by various inhibitors. Inhibition from protein kinase c isoenzymes (1996)
    Michael Gschwendt, Walter Kittstein et al. FEBS Letters

Immediate Impact

6 by Nobel laureates 24 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
2 intermediate papers

Works of Michael Gschwendt being referenced

Conventional PKC-α, Novel PKC-ε and PKC-θ, but Not Atypical PKC-λ Are MARCKS Kinases in Intact NIH 3T3 Fibroblasts
1997
Rottlerin, a Novel Protein Kinase Inhibitor
1994 Standout

Author Peers

Author Last Decade Papers Cites
Michael Gschwendt 3362 383 533 583 89 4.5k
Michiaki Kohno 3056 283 522 392 91 4.5k
Robbert H. Cool 4454 687 666 645 84 5.7k
Marco Castagna 3372 300 561 639 67 6.2k
Katsuji Yoshioka 3475 340 740 527 96 4.8k
Joseph J. Baldassare 2716 297 1003 538 96 4.3k
Jongsun Park 3948 264 442 647 126 5.6k
Paul Shapiro 3272 216 686 636 79 5.3k
Rosemary O’Connor 3065 310 417 713 99 5.2k
Louis C. Mahadevan 5080 469 530 725 52 6.4k
Shigemi Matsuyama 4290 293 440 729 72 5.6k

All Works

Loading papers...

Rankless by CCL
2026